Year: 2026
-
Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer
BOSTON, March 12, 2026 – Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, today announced the appointment of Colin Hayward, MBBS, FFPM, as the company’s Chief Medical Officer. Dr. Hayward brings more